Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Papadopoulos, Nickolas

Class:IdPerson:6802133
_displayNamePapadopoulos, Nickolas
_timestamp2015-10-02 17:01:03
created[InstanceEdit:6802128] Rothfels, Karen, 2015-10-02
firstnameNickolas
initialN
surnamePapadopoulos
(author)[LiteratureReference:6802126] The consensus coding sequences of human breast and colorectal cancers
[LiteratureReference:9652722] Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1
[LiteratureReference:9671768] DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors
[LiteratureReference:9673024] TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
[LiteratureReference:9706920] Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
[LiteratureReference:9706933] Altered telomeres in tumors with ATRX and DAXX mutations
[Change default viewing format]
No pathways have been reviewed or authored by Papadopoulos, Nickolas (6802133)